Long-Term Potentiation (LTP) in the Central Amygdala (CeA) is enhanced after prolonged withdrawal from chronic cocaine and requires CRF1 receptors

Journal of Neurophysiology

Volumn 97, Issue 1, 2007, Pages 937-941

  Fu, Yu ^a   Pollandt, Sebastian ^a   Liu, Jie ^a   Krishnan, Balaji ^a   Genzer, Kathy ^a   Orozco Cabal, Luis ^a   Gallagher, Joel P ^a   Shinnick Gallagher, Patricia ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM CHANNEL L TYPE; COCAINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SYNAPTIC POTENTIAL; WITHDRAWAL SYNDROME;

AMYGDALA; ANIMALS; CALCIUM CHANNELS, L-TYPE; CHRONIC DISEASE; COCAINE; COCAINE-RELATED DISORDERS; CUES; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; ELECTRIC STIMULATION; LONG-TERM POTENTIATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 33846439415     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00349.2006     Document Type: Article

References (41)

1. Aggleton JP. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. New York: WileyLiss, 1992.
2. Blank T, Nijholt I, Eckart K, Spiess J. Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J Neurosci 22: 3788-3794, 2002.
3. Brown EE, Robertson GS, Fibiger HC. Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. J Neurosci 12: 4112-4121, 1992.
4. Carey RJ, Gui J. Cocaine conditioning and cocaine sensitization: what is the relationship. Behav Brain Res 92: 67-76, 1998.
5. Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15: 6340-6350, 1995.
6. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156: 11-18, 1999.
7. Ciccocioppo R, Sanna PP, Weiss F. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc Natl Acad Sci USA 98: 1976-1981, 2001.
8. De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology (Berl) 143: 254-260, 1999.
9. Fu Y, Liu J, Gallagher JP, Shinnick-Gallagher P. Cocaine withdrawal enhances corticotropin releasing factor (CRF) dependent long-term potentiation (LTP) in the central amygdala. Soc Neurosci Abstr 855: 14, 2004.
10. Fu Y, Shinnick-Gallagher P. Two intra-amygdaloid pathways to the central amygdala exhibit different mechanisms of long-term potentiation. J Neurophysiol 93: 3012-3015, 2005.
11. Goussakov I, Chartoff EH, Tsvetkov E, Gerety LP, Meloni EG, Carlezon WA, Bolshakov VY. LTP in the lateral amygdala during cocaine withdrawal. Eur J Neurosci 23: 239-250, 2006.
12. Hayes RJ, Vorel SR, Spector J, Liu X, Gardner EL. Electrical and chemical stimulation of the basolateral complex of the amygdala reinstates cocaine-seeking behavior in the rat. Psychopharmacology (Berl) 168: 75-83, 2003.
13. Kalivas PW, Alesdatter JE. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267: 486-495, 1993.
14. Kalivas PW, Duffy P, DuMars LA, Skinner C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther 245: 485-492, 1988.
15. Lin CH, Yeh SH, Lin CH, Lu KT, Leu TH, Chang WC, Gean PW. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31: 841-851, 2001.
16. Liu J, Yu B, Neugebauer V, Grigoriadis DE, Rivier J, Vale WW, Shinnick-Gallagher P, Gallagher JP. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission. J Neurosci 24: 4020-4029, 2004.
17. Liu J, Yu B, Orozco-Cabal L, Grigoriadis DE, Rivier J, Vale WW, Shinnick-Gallagher P, Gallagher JP. Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum. J Neurosci 25: 577-583, 2005.
18. Loftis JM, Janowsky A. Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal. J Neurochem 75: 2040-2050, 2000.
19. Nasif FJ, Hu XT, White FJ. Repeated cocaine administration increases voltage-sensitive calcium currents in response to membrane depolarization in medial prefrontal cortex pyramidal neurons. J Neurosci 25: 3674-3679, 2005.
20. Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LT, Palmer A, Marshall JF. Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 20: 798-805, 2000.
21. Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 303: 1512-1514, 2004.
22. Pierce RC, Quick EA, Reeder DC, Morgan ZR, Kalivas PW. Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 286: 1171-1176, 1998.
23. 1 and PKA. Eur J Neurosci 24: 1733-1743, 2006.
24. Radulovic J, Sydow S, Spiess J. Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J Neurosci Res 54: 507-521, 1998.
25. Reimer AR, Martin-Iverson MT. Nimodipine and haloperidol attenuate behavioural sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine. Psychopharmacology (Berl) 113: 404-410, 1994.
26. Richter RM, Pich EM, Koob GF, Weiss F. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett 187: 169-172, 1995.
27. Richter RM, Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32: 254-261, 1999.
28. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291, 1993.
29. Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ. Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci USA 99: 13908-13913, 2002.
30. Sarnyai Z, Hohn J, Szabo G, Penke B. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sci 51: 2019-2024, 1992.
31. Sarnyai Z, Shaham Y, Heinrichs SC. The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53: 209-243, 2001.
32. Shinnick-Gallagher P, Pitkanen A, Shekhar A, Cahill L. The Amygdala in Brain Function: Basic and Clinical Implications. New York: New York Academy of Sciences, 2003.
33. Thomas KL, Arroyo M, Everitt BJ. Induction of the learning and plasticity-associated gene Zif268 following exposure to a discrete cocaine-associated stimulus. Eur J Neurosci 17: 1964-1972, 2003.
34. Thompson AM, Gosnell BA, Wagner JJ. Enhancement of long-term potentiation in the rat hippocampus following cocaine exposure. Neuropharmacology 42: 1039-1042, 2002.
35. Thompson AM, Swant J, Gosnell BA, Wagner JJ. Modulation of long-term potentiation in the rat hippocampus following cocaine self-administration. Neuroscience 127: 177-185, 2004.
36. Tian JB, Bishop GA. Frequency-dependent expression of corticotropin releasing factor in the rat's cerebellum. Neuroscience 121: 363-377, 2003.
37. Turchan J, Maj M, Przewlocka B. The effect of drugs of abuse on NMDAR1 receptor expression in the rat limbic system. Drug Alcohol Depend 72: 193-196, 2003.
38. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A. Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39: 401-407, 2003.
39. Wang HL, Wayner MJ, Chai CY, Lee EH. Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur J Neurosci 10: 3428-3437, 1998.
40. Zinebi F, Xie J, Liu J, Russell RT, Gallagher JP, McKernan MG, Shinnick-Gallagher P. NMDA currents and receptor protein are down-regulated in the amygdala during maintenance of fear memory. J Neurosci 23: 10283-10291, 2003.
41. Zorrilla EP, Valdez GR, Weiss F. Changes in levels of regional CRF-likeimmuno-reactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 158: 374-381, 2001.